Iovance Biotherapeutics Signs New Headquarters Lease and Terminates Previous Lease Agreement
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a Delaware-based biotechnology company, has recently announced significant changes in its office locations and lease agreements. On November 15, 2024, the company finalized a sublease agreement with Vaxcyte, Inc. for Suite 100 at 825 Industrial Road, San Carlos, California. This move comes as part of the company’s strategic initiatives to […]
More Stories
Horizon Kinetics Medical ETF (NASDAQ:MEDX) Plans Dividend of $0.50
Horizon Kinetics Medical ETF (NASDAQ:MEDX – Get Free Report) announced a dividend on Monday, December 23rd,NASDAQ Dividends reports. Stockholders of...
JPMorgan Sustainable Infrastructure ETF (NASDAQ:BLLD) Plans Dividend Increase – $1.76 Per Share
JPMorgan Sustainable Infrastructure ETF (NASDAQ:BLLD – Get Free Report) announced a dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...
Lazard Global Total Return and Income Fund, Inc. (NYSE:LGI) Increases Dividend to $0.15 Per Share
Lazard Global Total Return and Income Fund, Inc. (NYSE:LGI – Get Free Report) declared a dividend on Monday, December 23rd,NASDAQ...
OPG Power Ventures (LON:OPG) Trading Down 7.7% – Time to Sell?
OPG Power Ventures Plc (LON:OPG – Get Free Report) fell 7.7% during trading on Tuesday . The company traded as...
Wahed Dow Jones Islamic World ETF (NASDAQ:UMMA) to Issue Dividend of $0.00
Wahed Dow Jones Islamic World ETF (NASDAQ:UMMA – Get Free Report) announced a dividend on Monday, December 23rd,NASDAQ Dividends reports....
Themes Gold Miners ETF (NASDAQ:AUMI) Plans Dividend of $0.65
Themes Gold Miners ETF (NASDAQ:AUMI – Get Free Report) announced a dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...